Luis R. Castellanos, MD, MPH, Appointed Director of Diversity in Medicine and Faculty Outreach for the Department of Medicine

February 27, 2017

An announcement from Wolfgang H. Dillmann, MD, Helen M. Ranney Distinguished Professor and Chair, Department of Medicine

Luis Castellanos, MD, MPH

Luis Castellanos, MD, MPH

We are pleased to announce the appointment of Luis R. Castellanos, MD, MPH as Director of Diversity in Medicine and Faculty Outreach for the UCSD Department of Medicine.  Dr. Castellanos is an Associate Clinical Professor in the Division of Cardiology.

In his new role, he will work to promote the recruitment, retention and advancement of diverse medical professionals, including internal medicine residents and faculty, from underrepresented in medicine minority (URM) groups within the Department of Medicine.  Dr. Castellanos has demonstrated a sustained commitment to the critical mission of improving diversity and promoting inclusion in the medical field in order to better serve the members of our diverse community.

Dr. Castellanos graduated from UC Davis summa cum laude and Phi Beta Kappa, with a Bachelor of Science in biochemistry and earned his medical degree from Harvard Medical School.  He first joined UCSD as an Internal Medicine resident in 2003. He was then completed a prestigious Fellowship in Minority Health Policy at Harvard University/Commonwealth Fund Program, obtaining a Masters in Public Health with an emphasis in Health Policy and Management at the Harvard School of Public Health.

Dr. Castellanos subsequently completed a fellowship in cardiovascular medicine at UC Davis where he was selected as the Chief Research Fellow for his involvement in clinical research that addressed vulnerable populations.  He joined the faculty at UCSD in 2010.

As part of his clinical service, Dr. Castellanos travels to the Imperial Valley to provide cardiac care to underserved populations from El Centro, Brawley and neighboring communities.

Dr. Castellanos’ research focuses on health outcomes and inequities involving racial and ethnic minority groups.  He has co-authored peer-reviewed articles in the American Journal of Cardiology and the Journal of Cardiac Failure.  Dr. Castellanos was awarded a research grant from the Clinical and Translation Research Institute to study the effectiveness of a home-based cardiac rehabilitation program in patients with coronary heart disease who live in rural communities.  He has been invited to present his research at national conferences such as the American Heart Association and the National Hispanic Medical Association annual meetings where he has been a strong advocate for improving cardiovascular heath of vulnerable populations.

Dr. Castellanos has been recognized by the UCSD Clinical Advancement and Recognition of Excellence in Service and received the National Center for Leadership in Academic Medicine Award in 2013. Most recently, Dr. Castellanos was selected as a UCSD LEAD (Leaders for Equity, Advancement and Diversity) Fellow.

Dr. Daniel Bouland Appointed Chief of the Division of Hospital Medicine

Wolfgang H. Dillmann, MD

Wolfgang H. Dillmann, MD

Wolfgang Dillmann, MD, Helen M. Ranney Distinguished Professor and Chair of the Department of Medicine

The Department of Medicine is very pleased to announce the appointment of Dr. Daniel Bouland as chief of the Division of Hospital Medicine effective July 1, 2016. Dr. Bouland will work with the Chair of Medicine and the CEO of the Health System to ensure continued growth of the division; additionally, Dr. Bouland will also continue to support the department of medicine in a new role as Vice Chair for Clinical Quality Improvement and Patient Experience.

Dr. Daniel L. Bouland

Daniel L. Bouland, MD, MS, FACP

Dr. Bouland is highly regarded as a clinician and educator as well as being an experienced leader in health care management and administration with vast experience in the field of hospital medicine across various governmental and private sectors.

Dr. Bouland received his medical training at Loma Linda University School of Medicine and completed an internal medicine residency at the same institution, serving an additional year as chief medical resident at affiliated Riverside General Hospital/University Medical Center (RGH/UMC). Commitments with the United States Public Health Service afforded Dan opportunities to work with indigent populations in southern California as well as the Indian Health Service. Upon his subsequent return to RGH/UMC, Dr. Bouland was progressively appointed Assistant, Associate, and then Chair of the Department of Medicine. During this time, additional functions included vice-chair of the Department of Medicine and Associate Program Director, Internal Medicine Residency Program, Loma Linda University Medical Center; president of hospital-based physicians RGH/UMC; and CEO/President of the Mission Medical Group of the Inland Empire. Of note internationally, in addition to lectures and clinical care, is his establishing and maintaining a US-style medicine residency program at Sir Run Run Shaw Hospital, Zhejiang Medical University in Hangzhou, China.

In 2000, Dan moved to Hawaii to serve as Associate Chief of Staff for Primary Care and Medicine of the Veterans Affairs Pacific Islands Health Care System (VAPIHCS), and then as Director of the Office of Referral and Management Services of the VAPIHC.

After joining the UCSD Division of Hospital Medicine in 2006, Dan completed a Master’s program in Health Care Management at Harvard. He has taken on many leadership roles within the University, including serving as Vice Chair for Clinical Operations in the department of medicine and as Director of Evaluation for the Altman Clinical and Translational Research Institute.

Current research efforts focus primarily on Quality Improvement initiatives, particularly the application of a results-oriented, business management approach to health care.

Please join me in congratulating Dr. Bouland in his formal appointment as Chief of the Division of Hospital Medicine.

Poison Drummer Rikki Rockett Cancer-Free Following Immunotherapy at UC San Diego Health

Rikki Rockett, drummer for the band Poison, got the best news of his life last week: his cancer is gone. Rockett was diagnosed with oral cancer more than a year ago. Several months ago, he came to Moores Cancer Center at UC San Diego Health, where he underwent experimental cancer immunotherapy, which has now eradicated the tumor.

Rockett says he joined the clinical trial not only out of concern about himself, but also about being around for his three-year-old daughter, Lucy, and his seven-year-old son, Jude. … Read the Full Story by Heather Buschman from the UC San Diego Newsroom